Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Gains from Investment Securities (2023 - 2025)

Upstream Bio has reported Gains from Investment Securities over the past 3 years, most recently at $8.0 million for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $8.0 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $8.0 million (changed N/A YoY), and the annual figure for FY2025 was $8.0 million, up 22.65%.
  • Gains from Investment Securities for Q4 2025 was $8.0 million at Upstream Bio, down from $8.1 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for UPB hit a ceiling of $8.1 million in Q3 2025 and a floor of $3000.0 in Q4 2023.
  • Median Gains from Investment Securities over the past 3 years was $5.6 million (2024), compared with a mean of $4.9 million.
  • Peak annual rise in Gains from Investment Securities hit 153.55% in 2025, while the deepest fall reached 153.55% in 2025.
  • Upstream Bio's Gains from Investment Securities stood at $3000.0 in 2023, then surged by 106870.67% to $3.2 million in 2024, then soared by 148.07% to $8.0 million in 2025.
  • The last three reported values for Gains from Investment Securities were $8.0 million (Q4 2025), $8.1 million (Q3 2025), and $2.1 million (Q2 2025) per Business Quant data.